Kitsng, Fridelyn .

HRN: 12-99-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2023
CEFUROXIME 1.5GM (VIAL)
03/14/2023
03/14/2023
IV
1.5 Grams
Now
Prophylaxis To OR
Waiting Final Action 
03/14/2023
CEFUROXIME 1.5GM (VIAL)
03/14/2023
03/21/2023
IV
1.5gram
Q 8hrs
S/P Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: